RecruitingPHASE2, PHASE3NCT05696691

Ketamine & Crisis Response Plan for Suicidal Ideation in the ED

Studying Infantile neuroaxonal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The University of Texas Health Science Center at San Antonio
Principal Investigator
Robert De Lorenzo, MD, MSM
The University of Texas Health Science Center at San Antonio
Intervention
Ketamine Hydrochloride(drug)
Enrollment
24 target
Eligibility
18-70 years · All sexes
Timeline
20232026

Study locations (1)

Collaborators

National Center for Advancing Translational Sciences (NCATS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05696691 on ClinicalTrials.gov

Other trials for Infantile neuroaxonal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Infantile neuroaxonal dystrophy

← Back to all trials